"The Report
PharmaLeaders: CRO Benchmark Report - Financial Performance
Benchmarking & Competitive Landscape Assessment of Leading CROs
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
The
CRO
Benchmark Report
applies GlobalDatas proprietary ranking methodology to compare the
competitive positions of 11 leading CRO companies on 17 financial
metrics. These companies are analyzed based on financial performance,
cost-containment, capital structure and firm utilization to
illustrate the different strategies these companies are using to
increase value for their shareholders. Throughout the report,
GlobalDatas Industry Dynamics Team provides you with expert insight,
expanding on each of the metrics discussed. In addition to the
financial metrics, this report discusses trends impacting the CRO
marketplace, along with partnering and acquisition activity, and
operations strategy. This report also provides drill-down analyses of
three service lines and four geographies examining each of these
segments revenue and growth leaders, and business development
strategies. Lastly, this report provides GlobalDatas outlook on the
CRO sector and each companys future competitive position.
Download Sample copy of this
Report at : http://www.marketresearchreports.biz/sample/sample/173553
Highlights
About the Report
The
CRO market is highly fragmented comprised of some 1,000 individual
companies, most of which are privately owned. These companies vary
significantly in size and breadth of services from a four person
bioanalysis research lab in Thailand to companies like Quintiles and
Covance which have tens of thousands of employees in over 100
countries across the globe. GlobalData identified 11 CROs to apply
its benchmarking methodology providing a foundation for strategic
discussion and analysis. GlobalDatas coverage examines these CROs
from a unique company-centric lens combining financial performance
and resources allocation with partnering activity and regional
developments to assess a companys overall strategy. This type of
coverage is unlike any other analysis available, and delivers a
consistent view into the evolution of these companies corporate
growth. We also covered some 30 other privately-held CROs to give our
analysis more specificity and granularity.
Key Questions Answered
- What specific strategies are these CROs employing to gain market share?
- What drivers accounted for the revenue growth for the company over the past year?
- Which trends will affect the CRO marketplace over the next few years?
- What particular services or capabilities are my competitors developing?
- Who are the revenue and growth leaders in each service line and geography?
- What specific business development activities are taking place, in terms of partnerships or M&A?
- How are CROs growing their physical infrastructures and human resources to better serve the needs of their customers?
- What region-specific operations and capabilities are CROs adding to gain share in emerging markets?
Follow us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Scope
- Analysis of the key drivers and trends shaping the global CRO market; including biologics manufacturing, emerging markets, and eClinical technologies
- A deep dive into the synergies behind partnering and acquisition activity
- Discussion of business line and regional segment strategies
- Assessments of company financials by revenue, margin, expense and capital structure
- Firm utilization, resources management, and efficiency metrics
- Leadership/management changes
Reasons to buy
- Analyze and track the strategies that these CROs are using to gain share in the increasingly competitive market
- Understand the underlying financial metrics that differentiate certain companies from the pack in terms of growth and profitability, spending and asset structure
- Organize your sales and marketing strategy to identify companies with proprietary technologies to maximize opportunities for strategic investment or partnerships
- Use this information as an independent source for your due diligence and transaction strategy
Table of Contents
1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 14
1.2 List of Figures 14
2 Introduction 17
2.1 Report Scope 17
2.1.1 GlobalData Selection
Criteria 18
2.1.2 Companies Financially
Benchmarked 18
2.1.3 Other Companies Covered
18
2.2 Upcoming Reports 19
2.3 Recently Published Reports
19
2.4 GlobalDatas Benchmarking
Methodology 20
2.5 GlobalData CRO Benchmark
Leader: EPS Corporation 20
3 CRO Market Dynamics 22
3.1 Outsourcing Service
Delivery Models 22
3.1.1 Fully Integrated Service
Model 22
3.1.2 Functional Service Model
23
3.1.3 The Bottom Line: Use a
Hybrid Approach 24
3.2 Quintiles Goes Public 24
3.2.1 Quintiles IPO Raises
$947M, Pricing an Increased Number of Shares at Top Range 24
3.3 Weak Demand for Preclinical
Services Causes CROs to Economize 25
3.4 CROs Are Transitioning into
Becoming Experts in Biologics Manufacturing 26
3.4.1 WuXi Will Become a Leader
in Biologics Manufacturing through its Multi-pronged Strategy 27
3.4.2 Catalent Opens New
Manufacturing Center for Biologic Drug Development 29
3.4.3 ShangPharma Inks Two mAb
Partnerships 30
3.5 Emerging Locations in Asia
Will See the Greatest Investment and Growth 31
3.5.1 Location, Location
Footprint Growth Has Become More Important than Cost Reduction 31
3.5.2 Will Concerns about
Patient Safety Bring Down the Indian Clinical Trial Market? 33
3.6 eClinical Technologies Will
be Key Drivers to Accelerating Time-to-Market 35
3.6.1 Icon and Cerner Team Up
to Streamline Late-Phase Studies 35
3.6.2 Parexel Introduces
MyTrials Platform 36
3.6.3 INC Research Expands
Partnership with Medidata Solutions 37
3.6.4 Quintiles Unveils its
Next-Generation Infosario Analytics Platform 37
3.6.5 Covance Launches
Xcellerate to Increase Clinical Trial Optimization 38
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment